NorthCrest Asset Manangement LLC Acquires 2,068 Shares of UnitedHealth Group Incorporated $UNH

NorthCrest Asset Manangement LLC increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 9.6% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 23,639 shares of the healthcare conglomerate’s stock after buying an additional 2,068 shares during the quarter. NorthCrest Asset Manangement LLC’s holdings in UnitedHealth Group were worth $7,294,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of the company. Brighton Jones LLC raised its position in shares of UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after acquiring an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC raised its position in shares of UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after acquiring an additional 2,324 shares during the last quarter. Two Sigma Advisers LP acquired a new stake in UnitedHealth Group during the fourth quarter worth approximately $14,063,000. Woodline Partners LP acquired a new stake in UnitedHealth Group during the fourth quarter worth approximately $26,637,000. Finally, Waverly Advisors LLC grew its stake in UnitedHealth Group by 69.8% during the fourth quarter. Waverly Advisors LLC now owns 20,522 shares of the healthcare conglomerate’s stock worth $10,381,000 after purchasing an additional 8,433 shares during the period. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Trading Up 0.5%

UNH opened at $341.46 on Thursday. The business has a 50 day simple moving average of $294.30 and a two-hundred day simple moving average of $367.06. The firm has a market capitalization of $309.25 billion, a price-to-earnings ratio of 14.79, a PEG ratio of 2.22 and a beta of 0.45. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company’s revenue for the quarter was up 12.9% on a year-over-year basis. During the same period in the previous year, the company earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be issued a dividend of $2.21 per share. The ex-dividend date is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.6%. UnitedHealth Group’s dividend payout ratio is 38.30%.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on UNH. Royal Bank Of Canada reduced their price objective on UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating for the company in a research note on Wednesday, July 30th. Oppenheimer reduced their price objective on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a research note on Wednesday, July 30th. Wall Street Zen cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Saturday, May 24th. Hsbc Global Res lowered UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a report on Wednesday, May 21st. Finally, JPMorgan Chase & Co. dropped their target price on UnitedHealth Group from $418.00 to $310.00 and set an “overweight” rating on the stock in a report on Wednesday, August 6th. Sixteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $358.95.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.